✦ LIBER ✦

Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study

✍ Scribed by Lerolle, N.; Raffoux, E.; Socie, G.; Touratier, S.; Sauvageon, H.; Porcher, R.; Bretagne, S.; Bergeron, A.; Azoulay, E.; Molina, J.-M.; Lafaurie, M.

Book ID: 125440918
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 199 KB
Volume: 20
Category: Article
ISSN: 1198-743X
DOI: 10.1111/1469-0691.12688

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

83: Incidence and mortality of invasive

83: Incidence and mortality of invasive fungal infections in high-risk patients receiving posaconazole versus fluconazole or itraconazole prophylaxis

✍ A. Langston; J.H. Lipton; O.A. Cornely; A.J. Ullmann; H. Patino; C. Hardalo; D.J 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Phase 1B Study of the Pharmacokinetics a

Phase 1B Study of the Pharmacokinetics and Safety of Posaconazole Intravenous Solution in Patients at Risk for Invasive Fungal Disease

✍ Maertens, J.; Cornely, O. A.; Ullmann, A. J.; Heinz, W. J.; Krishna, G.; Patino, 📂 Article 📅 2014 🏛 American Society for Microbiology 🌐 English ⚖ 287 KB

The incidence of invasive fungal infecti

The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole

✍ Barreto, Jason N.; Beach, Cassidy L.; Wolf, Robert C.; Merten, Julianna A.; Tosh 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

A multicenter, randomized trial of posac

A multicenter, randomized trial of posaconazole (POS) vs fluconazole (FLU) or itraconazole (ITZ) for prophylaxis of invasive fungal infections (IFIs) in neutropenic patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) receiving intensive chemotherapy

✍ D.J. Winston; O.A. Cornely; J. Maertens; J. Perfect; D. Helfgott; A.J. Ullmann; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Voriconazole Compared To Itraconazole Fo

Voriconazole Compared To Itraconazole For Primary Prophylaxis Of Invasive Fungal Infections (IFI) In Allogeneic Hematopoietic Cell Transplant (HCT) Recipients – Results Of The Improvit Study With One Year Follow Up

✍ D.I. Marks; C. Kibbler; G. Cook; A. Glasmacher; C.P. Heussel; P. Ribaud; C. Sola 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Mould-active compared with fluconazole p

Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials

✍ Ethier, M C; Science, M; Beyene, J; Briel, M; Lehrnbecher, T; Sung, L 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 512 KB